Nieminen Tuomo, Kööbi Tiit, Tammela Teuvo L J, Kähönen Mika
Department of Pharmacological Sciences, Medical School, University of Tampere, Tampere, Finland.
Clin Drug Investig. 2006;26(11):667-71. doi: 10.2165/00044011-200626110-00007.
We describe pronounced hypotension in a patient during orthostatic testing while receiving treatment with sildenafil and tamsulosin, but not with placebo. The patient was 71 years of age and had no history of orthostatic reactions. He had been diagnosed with benign prostatic hyperplasia (BPH) and glaucoma simplex (open-angle glaucoma). The only regular medication used was a combination of latanoprost and timolol one drop daily into each eye. The patient was among 16 men with BPH enrolled in a study of the haemodynamic effects of tamsulosin and sildenafil. The present patient was excluded from data analysis because of atypical reactions: he experienced a decrease in peripheral vascular resistance upon orthostasis during treatment with sildenafil and tamsulosin. This led to marked hypotension and cancellation of the tilt tests with both sildenafil alone (Riva-Rocci [RR] 75/50 mm Hg) and a combination of sildenafil and tamsulosin (RR 60/45 mm Hg); however, tamsulosin alone also lowered blood pressure to some extent (RR 100/80 mm Hg). In conclusion, even though sildenafil and tamsulosin are considered haemodynamically safe, they may induce considerable vasodilation and, subsequently, harmful hypotension in susceptible patients.
我们描述了一名患者在接受西地那非和坦索罗辛治疗期间进行直立试验时出现明显低血压,但使用安慰剂时未出现。该患者71岁,无直立反应史。他被诊断为良性前列腺增生(BPH)和单纯性青光眼(开角型青光眼)。唯一常规使用的药物是拉坦前列素和噻吗洛尔的组合,每天每只眼睛滴一滴。该患者是16名参与坦索罗辛和西地那非血流动力学效应研究的BPH男性患者之一。由于非典型反应,该患者被排除在数据分析之外:他在使用西地那非和坦索罗辛治疗期间直立时外周血管阻力降低。这导致明显低血压,单用西地那非(里瓦-罗西[RR]75/50 mmHg)以及西地那非和坦索罗辛联合使用(RR 60/45 mmHg)时倾斜试验均取消;然而,单用坦索罗辛也在一定程度上降低了血压(RR 100/80 mmHg)。总之,尽管西地那非和坦索罗辛在血流动力学上被认为是安全的,但它们可能会在易感患者中引起相当程度的血管舒张,进而导致有害的低血压。